中国抗MDA5抗体阳性皮肌炎患者WDFY4基因多态性与快速进展型间质性肺病相关
该研究在中国抗MDA5抗体阳性皮肌炎(MDA5+DM)患者中检测WDFY4 rs7919656位点,发现该位点次要等位基因A频率与健康对照相当,但GA+AA基因型与快速进展型间质性肺病(RPILD)发生相关(OR 2.11),多因素分析中为RPILD独立危险因素(OR 4.98),且该基因型与WDFY4在PBMC及肺活检中高表达相关。
要点
- WDFY4 rs7919656次要等位基因A频率在MDA5+DM及CADM中与健康对照相当。
- GA+AA基因型与MDA5+DM患者RPILD发生相关(OR 2.11,95%CI 1.21-3.69,P=0.007)。
- 多因素分析中该基因型为RPILD独立危险因素(OR 4.98,95%CI 1.59-17.19,P=0.008)。
核心结论
- WDFY4变异与中国MDA5+DM患者RPILD风险增加相关,而与疾病易感性无关。
研究设计与样本
- 对254例MDA5+DM患者(含190例临床无肌病性皮肌炎、53例MDA5-DM)、72例抗合成酶综合征患者和192例健康对照进行WDFY4 rs7919656基因分型并比较次要等位基因A频率。
- 采用逻辑回归评估WDFY4变异与临床表型的关联。
主要发现
- MDA5+DM和CADM中WDFY4 rs7919656次要等位基因A频率与健康对照相当。
- WDFY4变异(GA+AA基因型)与MDA5+DM中RPILD发生率显著相关(OR 2.11;95%CI 1.21,3.69;P=0.007)。
- 多因素分析中该变异为RPILD独立危险因素(OR 4.98;95%CI 1.59,17.19;P=0.008),其他公认危险因素包括用力肺活量占预计值百分比、一氧化碳弥散量占预计值百分比、血清铁蛋白和泼尼松龙暴露。
- 该变异与MDA5+DM患者PBMC中WDFY4较高表达相关,尤其在RPILD患者中。
- 携带该变异基因型的MDA5+DM-RPILD患者肺活检中亦观察到WDFY4过表达。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Anti-melanoma differentiation-associated gene 5 antibody positive dermatomyositis (MDA5+DM), is susceptible to development of rapidly progressive interstitial lung disease (RPILD), which has been predominantly reported in East Asia. A Japanese genome-wide study has identified a WDFY4 variant rs7919656 linkage. We sought to evaluate this genetic marker and exploit its possible clinical relevance in Chinese MDA5+DM. METHODS: We genotyped and compared the minor allele A frequency of WDFY4 rs7919656 in patients with MDA5+DM (n = 254) including 190 clinically amyopathic dermatomyositis (CADM), MDA5-DM (n = 53), anti-synthetases syndrome (ASyS, n = 72) and healthy controls (n = 192). Association of the WDFY4 variant with clinical phenotype was evaluated using logistic regression. RESULTS: Although the minor allele A frequencies of WDFY4 rs7919656 in MDA5+DM and CADM were comparable to that in healthy controls, we observed a significant correlation between the WDFY4 variant (GA+AA genotype) and the incidence of RPILD in MDA5+DM (OR: 2.11; 95% CI: 1.21, 3.69; P = 0.007). Moreover, this variant was an independent risk factor for RPILD in multivariate analysis (OR: 4.98; 95% CI: 1.59, 17.19; P = 0.008), along with other well-recognized risk factors, i.e. forced vital capacity % predicted, diffusing capacity for carbon monoxide % predicted, serum ferritin and prednisolone exposure. In addition, this variant was associated with higher expression of WDFY4 in PBMCs of MDA5+DM, especially those with RPILD. WDFY4 overexpression was also observed in lung biopsy of MDA5+DM-RPILD bearing the variant genotype. CONCLUSION: We found that the WDFY4 variant was associated with an increased risk of RPILD, not with disease susceptibility in Chinese MDA5+DM.
引用
- Guo L, Zhang X, Pu W, et al. WDFY4 polymorphisms in Chinese patients with anti-MDA5 dermatomyositis is associated with rapid progressive interstitial lung disease. Rheumatology (Oxford). 2023. PMID: 36637178. doi:10.1093/rheumatology/kead006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。